Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy

NCT03883919 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer
Pancreas Cancer
Cancer of the Pancreas

Interventions

DRUG: 5-FU
DRUG: Leucovorin
DRUG: Liposomal Irinotecan
DRUG: Paricalcitol
PROCEDURE: Serum and plasma blood samples
PROCEDURE: Tumor biopsy

Sponsor

Washington University School of Medicine

Collaborators

[object Object]